Related Experiment Video
Updated: Feb 19, 2026
08:13
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
71.9K
Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
Toru Hiyoshi1, Mutsunori Fujiwara2, Zemin Yao3
1Division of Diabetes and Endocrinology, Department of Internal Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
Journal of Biomedical Research
|November 2, 2017
Summary
High postprandial glucose and triglyceride levels are key risks for cardiovascular disease and arteriosclerosis, particularly in type 2 diabetes. Addressing these metabolic issues is crucial for vascular health.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Metabolic Syndrome
Background:
- Postprandial glucose levels significantly impact cardiovascular disease risk, exceeding fasting glucose effects.
- Elevated serum triglyceride levels, both fasting and postprandial, promote arteriosclerosis.
- Insulin resistance underlies abnormal blood glucose and lipid profiles in the postprandial state.
Purpose of the Study:
- To investigate the link between postprandial hyperglycemia, hypertriglyceridemia, and atherosclerosis.
- To explore the role of insulin resistance in these metabolic disturbances.
- To review therapeutic strategies for managing these conditions in type 2 diabetes mellitus.
Main Methods:
- Analysis of existing literature on postprandial glucose and triglyceride metabolism.
- Review of studies on insulin resistance and its metabolic consequences.
- Examination of therapeutic interventions for hyperglycemia and dyslipidemia.
Main Results:
- Postprandial hyperglycemia and hypertriglyceridemia create a cycle contributing to vascular atherosclerotic changes.
- Insulin resistance is identified as a central mechanism driving these abnormalities.
- Type 2 diabetes mellitus patients are particularly susceptible to these detrimental effects.
Conclusions:
- Postprandial metabolic dysregulation is a significant contributor to cardiovascular disease, especially in type 2 diabetes.
- Targeting insulin resistance and lipid metabolism is essential for preventing atherosclerosis.
- Therapeutic approaches focusing on antidiabetic agents and lipid-lowering compounds show promise.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
01:36Carbohydrate Metabolism
14.5K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.5K
01:20Pathophysiology of Diabetes
3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.8K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K